Kathryn E Wengel
Director; EVP, Chief TO and Risk Officer · 6 filings · Latest: Jun 11, 2026
JOHNSON & JOHNSON
LABCORP HOLDINGS INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JNJ | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Jun 11, 2026 | Sale | $241.15 | 10,000 | $2.4M | 114,287.874 | |
JNJ | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Jun 11, 2026 | Option Exercise | $115.67 | 10,000 | $1.2M | 124,287.874 | |
JNJ | Wengel Kathryn E | — | Jun 11, 2026 | Proposed Sale | $240.15 | 10,000 | $2.4M | — | |
JNJ | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Feb 15, 2026 | Option Exercise | $0.00 | 1,241 | — | 114,612.874 | |
JNJ | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Feb 13, 2026 | Option Exercise | $0.00 | 14,357 | — | 120,095.874 | |
LH | Kathryn E Wengel | Director | Feb 11, 2026 | Option Exercise | — | 897 | — | 4,133 | |
JNJ | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Feb 6, 2026 | Option Exercise | $101.87 | 38,945 | $4.0M | 133,225.874 |